Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Intelligent Bio Solutions (INBS) Gains from Investment Securities (2021 - 2023)

Intelligent Bio Solutions has reported Gains from Investment Securities over the past 3 years, most recently at $1386.0 for Q2 2023.

For Q2 2023, Gains from Investment Securities changed N/A year-over-year to $1386.0; the TTM value through Jun 2023 reached $1386.0, changed N/A, while the annual FY2023 figure was $1386.0, N/A changed from the prior year.
Gains from Investment Securities for Q2 2023 was $1386.0 at Intelligent Bio Solutions, roughly flat from $1386.0 in the prior quarter.
Over five years, Gains from Investment Securities peaked at $27706.0 in Q4 2022 and troughed at -$362667.0 in Q2 2021.
A 3-year average of -$83047.2 and a median of $1386.0 in 2023 define the central range for Gains from Investment Securities.